Semaglutide 5mg Sample – Exceptional Purity Confirmed
Manufacturer: LeoLab™
Sample: Semaglutide 5mg
Date: 22 NOV 2024
LeoLab™ has demonstrated its commitment to excellence with third-party validation of the purity and quality of its Semaglutide 5mg product. Independent testing conducted by Janoshik Analytical, a trusted name in pharmaceutical analysis, confirms that LeoLab™’s Semaglutide meets and exceeds industry standards. The test, performed on 22 November 2024 under Task Number 53114, evaluated batch G59774 and delivered outstanding results.
The test results revealed a remarkable purity level of 99.904%, ensuring that customers receive a product free from impurities and contaminants. Moreover, the precise mass of the Semaglutide sample was measured at 5.80 mg, surpassing the labeled amount, which underscores the accuracy and reliability of LeoLab™’s manufacturing processes. Such rigorous quality control is a hallmark of LeoLab™, reflecting their dedication to producing peptides that researchers can trust.